Aptamer Group plc, a developer of synthetic oligonucleotide-based binding reagents for life sciences applications, and ...

EFS Plastics calls for stronger policies and collaboration to boost post-consumer resin adoption amid low virgin plastic ...

On 17 December 2025, the World Health Organization (WHO) announced the prequalification of two rapid antigen diagnostic tests ...

TrinScreen HIV order signals renewed strength in global HIV testing market - Company also reports a key milestone of Adjusted EBITDA(1) positive operations in Q3 2025 and expects to achieve strong ...

The largest of the three agreements involves the Xin Feng Ming Group, which will establish an integrated industrial complex for polyester fibres and polymers ...

Detailed price information for Fulgent Genetics Inc (FLGT-Q) from The Globe and Mail including charting and trades.

Human immunodeficiency virus (HIV) infections are still fairly common and an estimated 40 million people worldwide are ...

In the middle of the Christmas dinner season, anisakis is back in the conversation: hake, anchovies in vinegar, ceviche, ...

DECLARATION is a Phase 3, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of VYD2311 in the prevention of COVID versus placebo, at three months, from a single intramu ...

Fulgent Genetics, Inc. FLGT recently entered into an agreement to acquire selected assets of Bako Diagnostics and to acquire ...

The US Food and Drug Administration cleared a number of molecular tests and immunoassays, as well as a clinical chemistry and a cellular deformation test.

The first contract was signed with the Chinese group Shen Feng Ming and includes the establishment of an integrated complex ...